A detailed history of Israel Englander (Millennium Management LLC) transactions in Kodiak Sciences Inc. stock. As of the latest transaction made, Millennium Management LLC holds 32,972 shares of KOD stock, worth $204,096. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,972
Previous 12,757 158.46%
Holding current value
$204,096
Previous $29,000 196.55%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.2 - $3.25 $44,473 - $65,698
20,215 Added 158.46%
32,972 $86,000
Q2 2024

Aug 14, 2024

SELL
$2.29 - $4.48 $471,927 - $923,247
-206,082 Reduced 94.17%
12,757 $29,000
Q1 2024

May 15, 2024

SELL
$3.01 - $7.45 $944,522 - $2.34 Million
-313,795 Reduced 58.91%
218,839 $1.15 Million
Q4 2023

Feb 14, 2024

SELL
$1.4 - $3.24 $945,064 - $2.19 Million
-675,046 Reduced 55.9%
532,634 $1.62 Million
Q2 2023

Aug 14, 2023

BUY
$4.3 - $9.48 $935,073 - $2.06 Million
217,459 Added 21.96%
1,207,680 $8.33 Million
Q1 2023

May 15, 2023

BUY
$4.81 - $8.88 $2.85 Million - $5.26 Million
591,842 Added 148.56%
990,221 $6.14 Million
Q4 2022

Feb 14, 2023

SELL
$6.52 - $8.05 $2.52 Million - $3.11 Million
-385,771 Reduced 49.2%
398,379 $2.85 Million
Q3 2022

Nov 14, 2022

BUY
$7.57 - $12.5 $2.21 Million - $3.65 Million
291,767 Added 59.26%
784,150 $6.07 Million
Q2 2022

Aug 15, 2022

SELL
$5.04 - $9.48 $2.84 Million - $5.34 Million
-563,347 Reduced 53.36%
492,383 $3.76 Million
Q1 2022

May 16, 2022

BUY
$7.09 - $89.45 $7.4 Million - $93.4 Million
1,043,961 Added 8870.43%
1,055,730 $8.15 Million
Q4 2021

Feb 14, 2022

SELL
$80.85 - $128.49 $127,985 - $203,399
-1,583 Reduced 11.86%
11,769 $998,000
Q3 2021

Nov 15, 2021

SELL
$81.97 - $106.94 $4.31 Million - $5.62 Million
-52,533 Reduced 79.73%
13,352 $1.28 Million
Q2 2021

Aug 16, 2021

BUY
$77.2 - $126.54 $3.92 Million - $6.42 Million
50,717 Added 334.37%
65,885 $6.13 Million
Q1 2021

May 17, 2021

SELL
$110.45 - $164.47 $1.34 Million - $2 Million
-12,131 Reduced 44.44%
15,168 $1.72 Million
Q4 2020

Feb 16, 2021

BUY
$60.78 - $154.03 $268,829 - $681,274
4,423 Added 19.33%
27,299 $4.01 Million
Q3 2020

Nov 16, 2020

SELL
$45.05 - $59.27 $4.33 Million - $5.7 Million
-96,110 Reduced 80.77%
22,876 $1.35 Million
Q2 2020

Aug 14, 2020

SELL
$42.74 - $66.25 $3.9 Million - $6.05 Million
-91,270 Reduced 43.41%
118,986 $6.44 Million
Q1 2020

May 14, 2020

BUY
$38.18 - $73.95 $132,408 - $256,458
3,468 Added 1.68%
210,256 $10 Million
Q4 2019

Feb 14, 2020

BUY
$13.9 - $76.65 $2.87 Million - $15.9 Million
206,788 New
206,788 $14.9 Million
Q3 2019

Nov 14, 2019

SELL
$10.24 - $17.57 $135,761 - $232,943
-13,258 Closed
0 $0
Q2 2019

Aug 15, 2019

SELL
$6.2 - $12.0 $98,859 - $191,340
-15,945 Reduced 54.6%
13,258 $155,000
Q2 2019

Aug 14, 2019

BUY
$6.2 - $12.0 $181,058 - $350,436
29,203 New
29,203 $80,000

Others Institutions Holding KOD

About Kodiak Sciences Inc.


  • Ticker KOD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,040,200
  • Market Cap $322M
  • Description
  • Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...
More about KOD
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.